FDA Approves EPLERENONE — Breckenridge Pharmaceutical, Inc.

Breckenridge Pharmaceuticals has secured FDA approval for ANDA 208283 regarding oral eplerenone, introducing an additional generic option that is expected to heighten market competition and increase accessibility for payers and patients.